What is the official website of BOTOX® Cosmetic (onabotulinumtoxinA) ?

The official website of BOTOX® Cosmetic (onabotulinumtoxinA) is https://hcp.botoxcosmetic.com/.

What is BOTOX® Cosmetic (onabotulinumtoxinA)'s cybersecurity risk score?

BOTOX® Cosmetic (onabotulinumtoxinA) has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has BOTOX® Cosmetic (onabotulinumtoxinA) experienced?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has BOTOX® Cosmetic (onabotulinumtoxinA) been affected by any supply chain cyber incidents ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have SOC 2 Type 1 certification ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) is not certified under SOC 2 Type 1.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have SOC 2 Type 2 certification ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) does not hold a SOC 2 Type 2 certification.

Does BOTOX® Cosmetic (onabotulinumtoxinA) comply with GDPR ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) is not listed as GDPR compliant.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have PCI DSS certification ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) does not currently maintain PCI DSS compliance.

Does BOTOX® Cosmetic (onabotulinumtoxinA) comply with HIPAA ?

According to Rankiteo, BOTOX® Cosmetic (onabotulinumtoxinA) is not compliant with HIPAA regulations.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have ISO 27001 certification ?

According to Rankiteo,BOTOX® Cosmetic (onabotulinumtoxinA) is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does BOTOX® Cosmetic (onabotulinumtoxinA) operate in ?

BOTOX® Cosmetic (onabotulinumtoxinA) operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does BOTOX® Cosmetic (onabotulinumtoxinA) have ?

BOTOX® Cosmetic (onabotulinumtoxinA) employs approximately 0 people worldwide.

Does BOTOX® Cosmetic (onabotulinumtoxinA) own any subsidiaries ?

BOTOX® Cosmetic (onabotulinumtoxinA) presently has no subsidiaries across any sectors.

How many LinkedIn followers does BOTOX® Cosmetic (onabotulinumtoxinA) have ?

BOTOX® Cosmetic (onabotulinumtoxinA)'s official LinkedIn profile has approximately 2,415 followers.

What is the NAICS classification code for BOTOX® Cosmetic (onabotulinumtoxinA) ?

BOTOX® Cosmetic (onabotulinumtoxinA) is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have a Crunchbase profile ?

No, BOTOX® Cosmetic (onabotulinumtoxinA) does not have a profile on Crunchbase.

Does BOTOX® Cosmetic (onabotulinumtoxinA) have a LinkedIn profile ?

Yes, BOTOX® Cosmetic (onabotulinumtoxinA) maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/botox-cosmetic-usa.

How many cybersecurity incidents has BOTOX® Cosmetic (onabotulinumtoxinA) experienced ?

As of July 29, 2026, Rankiteo reports that BOTOX® Cosmetic (onabotulinumtoxinA) has experienced 2 cybersecurity incidents.

How many peer or competitor companies does BOTOX® Cosmetic (onabotulinumtoxinA) have ?

BOTOX® Cosmetic (onabotulinumtoxinA) has an estimated 5,712 peer or competitor companies worldwide.

What types of cybersecurity incidents has BOTOX® Cosmetic (onabotulinumtoxinA) faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Vulnerability.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

BOTOX® Cosmetic (onabotulinumtoxinA) Vendor Cyber Rating & Cyber Score

botoxcosmetic.com

Add Your Compliance Badge

Please see Prescribing Information and Important Safety Information, including Boxed Warning, below. A leader in aesthetic neurotoxins for decades, BOTOX® Cosmetic is the only neurotoxin that’s FDA approved for simultaneous treatment in adults for 3 areas of the face: to temporarily improve the appearance of moderate to severe forehead line, lateral canthal lines, and glabellar lines.1-5 Follow our page to learn how BOTOX® Cosmetic can support you and your patients. REFERENCES: 1. BOTOX® Cosmetic Prescribing Information, July 2020. 2. Dysport® Prescribing Information, January 2023. 3. Xeomin® Prescribing Information, August 2021. 4. Jeuveau® Prescribing Information, January 2020. 5. Daaxify™ Prescribing Information, September 2022.

BC A.I CyberSecurity Scoring

Scoring History

BOTOX® Cosmetic (onabotulinumtoxinA) CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

AbbVie

Vulnerability

100

4/2026

EGAABB177565877...

BOTOX® Cosmetic (on...

Breach

100

6/2023

ABB0473723

Loading…

A.I.

BC Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for BC

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for BOTOX® Cosmetic (onabotulinumtoxinA) in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for BOTOX® Cosmetic (onabotulinumtoxinA) in 2026.

Incident Types BC vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for BOTOX® Cosmetic (onabotulinumtoxinA) in 2026.

Incident History - BC (X = Date, Y = Severity)

Loading…

SUBSIDIARY

BOTOX® Cosmetic (onabotulinumtoxinA) Subsidiaries

BC

Pharmaceutical Manufacturing

Website: https://hcp.botoxcosmetic.com/

Company Size: 0

AbbViePharmaceutical Manufacturing

AbbVie | ImmunologyPharmaceutical Manufacturing

AbbVie | OncologyPharmaceutical Manufacturing

AbbVie | UKPharmaceutical Manufacturing

AbbVie | NeurosciencePharmaceutical Manufacturing

AbbVie | FrancePharmaceutical Manufacturing

Eye CarePharmaceutical Manufacturing

Pharmacyclics, an AbbVie CompanyPharmaceutical Manufacturing

AbbVieEyetoEyePharmaceutical Manufacturing

AbbVie | VirologyPharmaceutical Manufacturing

AbbVie | EspañaPharmaceutical Manufacturing

AbbVie | AustraliaPharmaceutical Manufacturing

AbbVie Contract ManufacturingPharmaceutical Manufacturing

AbbVieEyetoEyePharmaceutical Manufacturing

Natrelle Breast ImplantsPharmaceutical Manufacturing

Allergan Aesthetics Plastic and Regenerative Medicine PortfolioMedical Equipment Manufacturing

Allergan Medical InstitutePharmaceutical Manufacturing

Allergan Aesthetics, an AbbVie CompanyPharmaceutical Manufacturing

Loading…

BOTOX® Cosmetic (onabotulinumtoxinA) Similar Companies

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Novartis

cb novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Loading…

NEWS

BOTOX® Cosmetic (onabotulinumtoxinA) CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

September 09, 2025 07:00 AM

BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced a new chapter for BOTOX® Cosmetic with the debut of "The One & Only"...

Read Article

June 24, 2024 07:00 AM

How to spot fake Botox, or 'Faux-Tox,' and other skincare dupes and beauty counterfeit knockoffs

Fake Botox, skincare dupes and counterfeit cosmetics are not only impacting wallets, but can also pose major health concerns.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-66064

SUMMARY

goshs is a feature-rich single-binary file server for red teamers and developers. Prior to 2.1.5, the httpserver/handler.go sendFile handler opened files using a cleaned path but derived the authorization filename from raw req.URL.Path, so a trailing slash could bypass .goshs ACL-file protection and block-list checks. This issue is fixed in version 2.1.5.

Published

Date2026-07-28

Updated

Date2026-07-28

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-66063

SUMMARY

goshs is a feature-rich single-binary file server for red teamers and developers. Prior to 2.1.5, the httpserver/updown.go multipart upload handler split part.FileName() on / but did not reject .., allowing an unauthenticated upload with filename .. to create a file outside the served tree. This issue is fixed in version 2.1.5.

Published

Date2026-07-28

Updated

Date2026-07-28

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

3.9

REFERENCES

CVE-2026-64863

SUMMARY

goshs is a feature-rich single-binary file server for red teamers and developers. Prior to 2.1.4, the httpserver/server.go wdGuard handled WebDAV MOVE as a write-only method and did not enforce --no-delete, allowing WebDAV clients to delete or overwrite files via MOVE with Overwrite: T. This issue is fixed in version 2.1.4.

Published

Date2026-07-28

Updated

Date2026-07-28

RISK INFORMATION (Score: 9.1)

cvss3

Base Score: 9.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:H

Impact Score

5.2

Exploitability

3.9

REFERENCES

CVE-2026-62325

SUMMARY

goshs is a feature-rich single-binary file server for red teamers and developers. From 2.1.3 until 2.1.4, the sftpserver/sftpserver.go password handler used Username != "" && Password != "", so running goshs with -b 'admin:' -sftp and no -fkf left both SFTP authentication handlers unset and allowed unauthenticated file access. This issue is fixed in version 2.1.4.

Published

Date2026-07-28

Updated

Date2026-07-28

RISK INFORMATION (Score: 9.1)

cvss3

Base Score: 9.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

Impact Score

5.2

Exploitability

3.9

REFERENCES

CVE-2026-59921

SUMMARY

Netty is an asynchronous, event-driven network application framework. Prior to versions 4.1.136.Final and 4.2.16.Final, HttpPostRequestEncoder constructs multipart HTTP request bodies by directly concatenating user-supplied filenames and field names into Content-Disposition MIME headers without validating or sanitizing CRLF characters (\r\n). Since MIME headers are delimited by CRLF, an attacker who controls the filename can inject arbitrary MIME headers into the multipart body part. The root cause is that neither the encoder nor the FileUpload implementations' setFilename() methods, which only check for null, neutralize CRLF characters before the filename is embedded into the header. This issue has been fixed in versions 4.1.136.Final and 4.2.16.Final.

Published

Date2026-07-28

Updated

Date2026-07-28

RISK INFORMATION (Score: 5.7)

cvss3

Base Score: 5.7

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N

Impact Score

3.6

Exploitability

2.1

REFERENCES

https://github.com/netty/netty/security/advisories/GHSA-gcjf-9mgh-3p7g

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…